Prognosis
Pfizer Says Booster Shots of Vaccine Restore Waning Immunity
- Presentation for FDA meeting details waning shot effectiveness
- FDA staff makes no recommendation on clearing third dose
This article is for subscribers only.
Pfizer Inc. said that data from the U.S. and Israel suggest that the efficacy of its Covid-19 vaccine wanes over time, and that a booster dose was safe and effective at warding off the virus and new variants.
The company detailed the data in a presentation it will deliver to a meeting of outside advisers to the Food and Drug Administration on Friday. The panel is expected to make recommendations for whether more Americans should receive booster shots.